Australia and New Zealand

Australia and New Zealand

Australian New Zealand Clinical Trials Registry (ANZCTR)

Verified on November 30, 2022

Australia and New Zealand have a World Health Organization (WHO) recognized primary registry, Australian New Zealand Clinical Trials Registry (ANZCTR). Registration of protocol and results posting is a voluntary requirement on ANZCTR.

Registries at a Glance
Registry PHUSE Categorization Information to be Entered By Route of Data in Registry Study Type Language
ANZCTR Mandatory National Database (includes Ethics Requirement) Sponsor Through a dedicated registration platform (process independent from clinical trial application), Populated via


(Phase 0-4);


Registration and Results Requirements
Registry Activity Legal Requirement Timing
ANZCTR Registration


Prior to enrollment


Not specified

Registry Updates

  • June 2022: Australia and New Zealand Update - An update posted on the Australia New Zealand Clinical Trial Registry (ANZCTR) informs users that a series of short, detailed videos for researchers or any authorized representatives explaining steps of registering a new trial on the ANZCTR are now available on their website. The series feature instructional videos demonstrating how to report interventions, outcome measures, … Continue reading "June 2022: Australia and New Zealand Update"
  • October 2018: Australia Updates - October 25, 2018: ANZCTR-Results Reporting From October 2018, additional data fields for study results is required in order to comply with the WHO 24 TRDS. Result fields will include date of results summaries, date of first journal publication of results, link(s) to results and publications, link to protocol file(s) with version date, baseline characteristics, participant … Continue reading "October 2018: Australia Updates"


  1. Frequently asked questions. Accessed in 2018.